World Health Organization site
Skip Navigation Links

Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: JPRN
Last refreshed on: 2 April 2019
Main ID:  JPRN-UMIN000006723
Date of registration: 14/11/2011
Prospective Registration: Yes
Primary sponsor: Osaka University Graduate School of Medicine
Public title: Clinical research of bone marrow-derived mesenchymal stem cell transplantation for the patients with epidermolysis bullosa.
Scientific title:
Date of first enrolment: 2011/12/01
Target sample size: 6
Recruitment status: Recruiting
Study type:  Interventional
Study design:  Single arm Non-randomized  
Phase:  Not selected
Countries of recruitment
Address:  2-15, Yamadaoka, Suita-shi, Osaka 565-0871, Japan Japan
Affiliation:  Osaka University Hospital Medical Center for Translational Research
Name: Katsuto Tamai   
Address:  2-2, Yamadaoka, Suita-shi, Osaka 565-0871, Japan Japan
Telephone: 06-6879-3902
Affiliation:  Osaka University Graduate School of Medicine Department of Stem Cell Therapy Science
Key inclusion & exclusion criteria
Inclusion criteria: 1) Patients diagnosed with epidermolysis bullosa (junctional or dystrophic type).
2) Patients aged 20-60 years old.
3) Patients with intractable skin ulcer which present for more than 6 weeks.
4) Patients who have opposite-sex parent or sibling with donor agreement.
5) Patients who agreed with written concent

Exclusion criteria: 1) Patients with severe psychotic disorders
2) Patients with alcoholic addiction
3) Patients with disturbance of consciousness
4) Patients with history of malignancy within the last 5 years
5) Patients with pregnancy
6) Patients with diabetes

Other patients who are evaluated not to be suitable for this research

Age minimum: 20years-old
Age maximum: 60years-old
Gender: Male and Female
Health Condition(s) or Problem(s) studied
Epidermolysis bullosa (junctional, dystrophic)
Subcutaneous transplantation of bone marrow mesenchymal stem cells
Primary Outcome(s)
Safety evaluation
(Adverse events)
Secondary Outcome(s)
Efficacy evaluation
(macroscopic and histological examination of the skin lesions)
Secondary ID(s)
Source(s) of Monetary Support
Secondary Sponsor(s)
Ethics review
Approval date:
Results available:
Date Posted:
Date Completed:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history